- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.30 Å
- Oligo State
- homo-hexamer
- Ligands
- 42 x SO4: SULFATE ION(Non-functional Binders)
- 12 x NHE: 2-[N-CYCLOHEXYLAMINO]ETHANE SULFONIC ACID(Non-covalent)
NHE.8: 8 residues within 4Å:- Chain A: F.85, L.86, G.87, F.88, Q.302
- Chain C: F.88
- Ligands: NHE.22, NHE.36
7 PLIP interactions:5 interactions with chain A, 2 interactions with chain C- Hydrogen bonds: A:F.85, A:F.85, A:G.87, A:F.88, A:Q.302
- Hydrophobic interactions: C:F.88, C:F.88
NHE.9: 7 residues within 4Å:- Chain A: F.335, F.425, Y.426, D.427, V.430, N.444, I.447
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:F.335, A:F.425, A:Y.426
- Hydrogen bonds: A:D.427, A:N.444
NHE.22: 8 residues within 4Å:- Chain A: F.88
- Chain B: F.85, L.86, G.87, F.88, Q.302
- Ligands: NHE.8, NHE.36
6 PLIP interactions:4 interactions with chain B, 2 interactions with chain A- Hydrogen bonds: B:F.85, B:G.87, B:F.88, B:Q.302
- Hydrophobic interactions: A:F.88, A:F.88
NHE.23: 7 residues within 4Å:- Chain B: F.335, F.425, Y.426, D.427, V.430, N.444, I.447
5 PLIP interactions:5 interactions with chain B- Hydrophobic interactions: B:F.335, B:F.425, B:Y.426
- Hydrogen bonds: B:D.427, B:N.444
NHE.36: 8 residues within 4Å:- Chain B: F.88
- Chain C: F.85, L.86, G.87, F.88, Q.302
- Ligands: NHE.8, NHE.22
7 PLIP interactions:5 interactions with chain C, 2 interactions with chain B- Hydrogen bonds: C:F.85, C:F.85, C:G.87, C:F.88, C:Q.302
- Hydrophobic interactions: B:F.88, B:F.88
NHE.37: 7 residues within 4Å:- Chain C: F.335, F.425, Y.426, D.427, V.430, N.444, I.447
5 PLIP interactions:5 interactions with chain C- Hydrophobic interactions: C:F.335, C:F.425, C:Y.426
- Hydrogen bonds: C:D.427, C:N.444
NHE.50: 8 residues within 4Å:- Chain D: F.85, L.86, G.87, F.88, Q.302
- Chain F: F.88
- Ligands: NHE.64, NHE.78
6 PLIP interactions:4 interactions with chain D, 2 interactions with chain F- Hydrogen bonds: D:F.85, D:G.87, D:F.88, D:Q.302
- Hydrophobic interactions: F:F.88, F:F.88
NHE.51: 7 residues within 4Å:- Chain D: F.335, F.425, Y.426, D.427, V.430, N.444, I.447
5 PLIP interactions:5 interactions with chain D- Hydrophobic interactions: D:F.335, D:F.425, D:Y.426
- Hydrogen bonds: D:D.427, D:N.444
NHE.64: 8 residues within 4Å:- Chain D: F.88
- Chain E: F.85, L.86, G.87, F.88, Q.302
- Ligands: NHE.50, NHE.78
7 PLIP interactions:5 interactions with chain E, 2 interactions with chain D- Hydrogen bonds: E:F.85, E:F.85, E:G.87, E:F.88, E:Q.302
- Hydrophobic interactions: D:F.88, D:F.88
NHE.65: 7 residues within 4Å:- Chain E: F.335, F.425, Y.426, D.427, V.430, N.444, I.447
5 PLIP interactions:5 interactions with chain E- Hydrophobic interactions: E:F.335, E:F.425, E:Y.426
- Hydrogen bonds: E:D.427, E:N.444
NHE.78: 8 residues within 4Å:- Chain E: F.88
- Chain F: F.85, L.86, G.87, F.88, Q.302
- Ligands: NHE.50, NHE.64
6 PLIP interactions:4 interactions with chain F, 2 interactions with chain E- Hydrogen bonds: F:F.85, F:G.87, F:F.88, F:Q.302
- Hydrophobic interactions: E:F.88, E:F.88
NHE.79: 7 residues within 4Å:- Chain F: F.335, F.425, Y.426, D.427, V.430, N.444, I.447
5 PLIP interactions:5 interactions with chain F- Hydrophobic interactions: F:F.335, F:F.425, F:Y.426
- Hydrogen bonds: F:D.427, F:N.444
- 30 x CL: CHLORIDE ION(Non-functional Binders)
CL.10: 5 residues within 4Å:- Chain A: N.164, I.165
- Chain E: N.164, I.165
- Ligands: CL.66
Ligand excluded by PLIPCL.11: 3 residues within 4Å:- Chain A: W.27, S.94
- Chain B: Y.406
Ligand excluded by PLIPCL.12: 3 residues within 4Å:- Chain A: K.263, W.289, A.303
Ligand excluded by PLIPCL.13: 3 residues within 4Å:- Chain A: Q.410, E.411
- Chain C: K.104
Ligand excluded by PLIPCL.14: 2 residues within 4Å:- Chain A: P.432, S.450
Ligand excluded by PLIPCL.24: 5 residues within 4Å:- Chain B: N.164, I.165
- Chain D: N.164, I.165
- Ligands: CL.52
Ligand excluded by PLIPCL.25: 3 residues within 4Å:- Chain B: W.27, S.94
- Chain C: Y.406
Ligand excluded by PLIPCL.26: 3 residues within 4Å:- Chain B: K.263, W.289, A.303
Ligand excluded by PLIPCL.27: 3 residues within 4Å:- Chain A: K.104
- Chain B: Q.410, E.411
Ligand excluded by PLIPCL.28: 2 residues within 4Å:- Chain B: P.432, S.450
Ligand excluded by PLIPCL.38: 5 residues within 4Å:- Chain C: N.164, I.165
- Chain F: N.164, I.165
- Ligands: CL.80
Ligand excluded by PLIPCL.39: 3 residues within 4Å:- Chain A: Y.406
- Chain C: W.27, S.94
Ligand excluded by PLIPCL.40: 3 residues within 4Å:- Chain C: K.263, W.289, A.303
Ligand excluded by PLIPCL.41: 3 residues within 4Å:- Chain B: K.104
- Chain C: Q.410, E.411
Ligand excluded by PLIPCL.42: 2 residues within 4Å:- Chain C: P.432, S.450
Ligand excluded by PLIPCL.52: 5 residues within 4Å:- Chain B: N.164, I.165
- Chain D: N.164, I.165
- Ligands: CL.24
Ligand excluded by PLIPCL.53: 3 residues within 4Å:- Chain D: W.27, S.94
- Chain E: Y.406
Ligand excluded by PLIPCL.54: 3 residues within 4Å:- Chain D: K.263, W.289, A.303
Ligand excluded by PLIPCL.55: 3 residues within 4Å:- Chain D: Q.410, E.411
- Chain F: K.104
Ligand excluded by PLIPCL.56: 2 residues within 4Å:- Chain D: P.432, S.450
Ligand excluded by PLIPCL.66: 5 residues within 4Å:- Chain A: N.164, I.165
- Chain E: N.164, I.165
- Ligands: CL.10
Ligand excluded by PLIPCL.67: 3 residues within 4Å:- Chain E: W.27, S.94
- Chain F: Y.406
Ligand excluded by PLIPCL.68: 3 residues within 4Å:- Chain E: K.263, W.289, A.303
Ligand excluded by PLIPCL.69: 3 residues within 4Å:- Chain D: K.104
- Chain E: Q.410, E.411
Ligand excluded by PLIPCL.70: 2 residues within 4Å:- Chain E: P.432, S.450
Ligand excluded by PLIPCL.80: 5 residues within 4Å:- Chain C: N.164, I.165
- Chain F: N.164, I.165
- Ligands: CL.38
Ligand excluded by PLIPCL.81: 3 residues within 4Å:- Chain D: Y.406
- Chain F: W.27, S.94
Ligand excluded by PLIPCL.82: 3 residues within 4Å:- Chain F: K.263, W.289, A.303
Ligand excluded by PLIPCL.83: 3 residues within 4Å:- Chain E: K.104
- Chain F: Q.410, E.411
Ligand excluded by PLIPCL.84: 2 residues within 4Å:- Chain F: P.432, S.450
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Krarup, A. et al., A highly stable prefusion RSV F vaccine derived from structural analysis of the fusion mechanism. Nat Commun (2015)
- Release Date
- 2015-09-23
- Peptides
- Fusion glycoprotein F0,Fibritin: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
AE
AF
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.30 Å
- Oligo State
- homo-hexamer
- Ligands
- 42 x SO4: SULFATE ION(Non-functional Binders)
- 12 x NHE: 2-[N-CYCLOHEXYLAMINO]ETHANE SULFONIC ACID(Non-covalent)
- 30 x CL: CHLORIDE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Krarup, A. et al., A highly stable prefusion RSV F vaccine derived from structural analysis of the fusion mechanism. Nat Commun (2015)
- Release Date
- 2015-09-23
- Peptides
- Fusion glycoprotein F0,Fibritin: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
AE
AF
A